Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 21.00 |
P173927
Closed
Andre Carletto
Republic of Gabon
May 6, 2020
(as of board presentation)
May 15, 2020
May 27, 2020
US$ 21.00 million
Commission nationale des travaux d'intérêt public pour la promotion de l'entrepreneuriat et de l'emp
2020
US$ 21.00 million
N/A
March 27, 2024
June 30, 2024
No
BANK APPROVED
Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 21.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | 21.00 |
IDA Commitment | N/A |
IBRD + IDA Commitment | 21.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 21.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
May 24, 2023 | IBRD-91240 | Int Charges | 3,870.46 |
May 24, 2023 | IBRD-91240 | Int Charges | 32.73 |
Nov 15, 2022 | IBRD-91240 | Loan Disb | -2,252.91 |
Nov 15, 2022 | IBRD-91240 | Loan Disb | 2,252.91 |
Nov 15, 2022 | IBRD-91240 | Int Charges | 1,086.64 |
Nov 15, 2022 | IBRD-91240 | Int Charges | 3,748.07 |
Nov 15, 2022 | IBRD-91240 | Int Charges | 110.33 |
Nov 15, 2022 | IBRD-91240 | Int Charges | 1.21 |
Nov 15, 2022 | IBRD-91240 | Int Charges | 10,456.56 |
Nov 15, 2022 | IBRD-91240 | Int Charges | 927.21 |
Sep 9, 2022 | IBRD-91240 | Loan Disb | 2,179.77 |
Dec 16, 2021 | IBRD-91240 | Int Charges | 445.36 |
Dec 16, 2021 | IBRD-91240 | Int Charges | 11,344.35 |
Dec 16, 2021 | IBRD-91240 | Int Charges | 1,002.53 |
May 15, 2022 | IBRD-91240 | Int Charges | 925.07 |
May 15, 2022 | IBRD-91240 | Loan Disb | -387,508.88 |
May 15, 2022 | IBRD-91240 | Loan Disb | 387,508.88 |
May 15, 2022 | IBRD-91240 | Int Charges | 1,084.12 |
Dec 3, 2021 | IBRD-91240 | Loan Disb | 421,846.75 |
May 15, 2022 | IBRD-91240 | Int Charges | 157.08 |
May 15, 2022 | IBRD-91240 | Int Charges | 3.12 |
May 15, 2022 | IBRD-91240 | Int Charges | 10,432.46 |
Nov 15, 2021 | IBRD-91240 | Loan Disb | -373,463.78 |
Nov 15, 2021 | IBRD-91240 | Loan Disb | 373,463.78 |
Aug 19, 2021 | IBRD-91240 | Loan Disb | 23,386.00 |
Jul 27, 2021 | IBRD-91240 | Loan Disb | 360,909.34 |
Mar 9, 2021 | IBRD-91240 | Loan Disb | 407,725.53 |
Dec 10, 2020 | IBRD-91240 | Int Charges | 10,049.74 |
May 15, 2021 | IBRD-91240 | Loan Disb | -414,935.38 |
May 15, 2021 | IBRD-91240 | Loan Disb | 414,935.38 |
May 18, 2021 | IBRD-91240 | Int Charges | 761.99 |
May 18, 2021 | IBRD-91240 | Int Charges | 12,260.25 |
Nov 15, 2020 | IBRD-91240 | Loan Disb | -8,477,569.00 |
Nov 15, 2020 | IBRD-91240 | Loan Disb | 8,477,569.00 |
Jun 19, 2020 | IBRD-91240 | Loan Disb | 6,225,051.00 |
May 27, 2020 | IBRD-91240 | Loan Disb | 22,860.28 |
May 27, 2020 | IBRD-91240 | Fee Charges | 22,860.28 |
Oct 7, 2020 | IBRD-91240 | Loan Disb | 1,877,351.50 |
May 15, 2020 | IBRD-91240 | Loan Commitment | 9,000,000.00 |
Oct 15, 2021 | IBRD-93040 | Loan Commitment | 12,000,000.00 |
Apr 24, 2024 | IBRD-91240 | Loan Disb | 1,982.30 |
Apr 24, 2024 | IBRD-91240 | Loan Disb | -1,982.30 |
Apr 24, 2024 | IBRD-91240 | Loan Disb | -36,123.73 |
Apr 24, 2024 | IBRD-91240 | Loan Disb | 36,123.73 |
Apr 24, 2024 | IBRD-91240 | Loan Disb | -38,106.02 |
Jul 5, 2024 | IBRD-91240 | Int Charges | 10,095.14 |
Jul 5, 2024 | IBRD-91240 | Loan Repay | 7.58 |
Jul 5, 2024 | IBRD-91240 | Int Charges | 111.37 |
Jul 5, 2024 | IBRD-91240 | Int Charges | 129.37 |
Jul 5, 2024 | IBRD-91240 | Loan Repay | 25,207.58 |
Jul 5, 2024 | IBRD-91240 | Loan Repay | 28,832.07 |
Jul 5, 2024 | IBRD-91240 | Loan Repay | 26,472.87 |
Jul 5, 2024 | IBRD-91240 | Loan Repay | 167.24 |
Jul 5, 2024 | IBRD-91240 | Int Charges | 895.16 |
Jul 5, 2024 | IBRD-91240 | Int Charges | 1,049.09 |
Jul 5, 2024 | IBRD-91240 | Int Charges | 3,618.54 |
Jul 5, 2024 | IBRD-91240 | Int Charges | 37.61 |
Jul 5, 2024 | IBRD-91240 | Loan Repay | 554,438.60 |
Jul 5, 2024 | IBRD-91240 | Int Charges | 11.47 |
Jul 5, 2024 | IBRD-91240 | Int Charges | 13.44 |
Jul 5, 2024 | IBRD-91240 | Int Charges | 46.37 |
Jul 5, 2024 | IBRD-91240 | Int Charges | 0.49 |
Dec 15, 2023 | IBRD-91240 | Loan Repay | 161.78 |
Dec 15, 2023 | IBRD-91240 | Int Charges | 976.81 |
Dec 15, 2023 | IBRD-91240 | Int Charges | 114.33 |
Dec 15, 2023 | IBRD-91240 | Int Charges | 7.68 |
Dec 15, 2023 | IBRD-91240 | Int Charges | 11,015.95 |
Dec 15, 2023 | IBRD-91240 | Int Charges | 1,144.77 |
Dec 15, 2023 | IBRD-91240 | Int Charges | 3,948.58 |
Dec 15, 2023 | IBRD-91240 | Int Charges | 41.07 |
Dec 15, 2023 | IBRD-91240 | Loan Repay | 561,814.06 |
Dec 15, 2023 | IBRD-91240 | Loan Repay | 25,542.91 |
Dec 15, 2023 | IBRD-91240 | Loan Repay | 26,825.03 |
Dec 15, 2023 | IBRD-91240 | Loan Repay | 29,215.61 |
May 24, 2023 | IBRD-91240 | Int Charges | 110.24 |
May 24, 2023 | IBRD-91240 | Int Charges | 10,798.02 |
May 24, 2023 | IBRD-91240 | Int Charges | 957.49 |
May 24, 2023 | IBRD-91240 | Int Charges | 1,122.12 |
Name | Review | Date |
---|---|---|
Procurement | Satisfactory | 2023-10-31 |
Progress towards achievement of PDO | Satisfactory | 2023-10-31 |
Project Management | Satisfactory | 2023-10-31 |
Financial Management | Satisfactory | 2023-10-31 |
Monitoring and Evaluation | Satisfactory | 2023-10-31 |
Overall Implementation Progress (IP) | Satisfactory | 2023-10-31 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents. | Value | 2.00 | 23.00 | 5.00 |
Date | April 7, 2020 | September 14, 2023 | June 30, 2022 | |
Comment |
Percentage of suspected cases of COVID-19 reported and investigated per approved protocol (Percentage) | Value | 0.00 | 60.00 | 60.00 |
Date | April 7, 2020 | September 14, 2023 | June 30, 2022 | |
Comment |
Percentage of diagnosed cases treated per approved protocol (Percentage) | Value | 0.00 | 100.00 | 70.00 |
Date | April 7, 2020 | September 14, 2023 | June 30, 2022 | |
Comment |
Percentage of population vaccinated, which is included in the priority population targets defined in the national plan | Value | 2.00 | 2.00 | 60.00 |
Date | June 30, 2021 | June 30, 2021 | June 30, 2024 | |
Comment |
Percentage of women vaccinated, which are included in the priority population targets defined in the national plan | Value | 0.60 | 0.60 | 50.00 |
Date | June 30, 2021 | June 30, 2021 | June 28, 2024 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Percentage of targeted sites where requested Cold Chain Equipment has been installed and functional | Value | 0.00 | 0.00 | 100.00 |
Date | June 30, 2021 | June 30, 2021 | June 30, 2024 | |
Comment |
Radio/TV Stations broadcast COVID-19 vaccine communication message in French and local languages | Value | No | No | Yes |
Date | June 30, 2021 | August 13, 2021 | June 30, 2024 | |
Comment |
Gender sensitive educational communication materials on COVID-19 vaccines distributed | Value | No | No | Yes |
Date | June 30, 2021 | August 13, 2021 | June 30, 2024 | |
Comment |
Share of female community health workers provided with vaccine information | Value | 0.00 | 0.00 | 40.00 |
Date | June 30, 2021 | August 31, 2021 | June 28, 2024 | |
Comment |
Share of vaccinators who are female | Value | 0.00 | 0.00 | 30.00 |
Date | June 30, 2021 | June 30, 2021 | June 28, 2024 | |
Comment |
Percentage of health staff equipped with appropriate PPE for infection prevention and control per MOH-approved protocols (Percentage). (Percentage) | Value | 50.00 | 95.00 | 80.00 |
Date | April 7, 2020 | September 14, 2023 | June 30, 2022 | |
Comment |
Number of suspected COVID19 cases tested per MOH-approved protocols at the 5 designated laboratories equipped to conduct COVID-19 diagnosis (number). (Number) | Value | 572.00 | 70000.00 | 60000.00 |
Date | April 7, 2020 | September 14, 2023 | June 30, 2022 | |
Comment |
M&E system established to monitor COVID-19 preparedness and response plan (Yes/No) | Value | No | Yes | Yes |
Date | April 7, 2020 | September 14, 2023 | June 30, 2022 | |
Comment |
Number of WB financed designated ambulances to transport COVID19 patients per MOH-approved protocols (number) (Number) | Value | 0.00 | 26.00 | 10.00 |
Date | April 7, 2020 | September 14, 2023 | June 30, 2022 | |
Comment |
Percentage of grievances received that were timely addressed through the GRM mechanism (Percentage) | Value | 0.00 | 0.00 | 70.00 |
Date | June 30, 2021 | August 13, 2021 | June 30, 2024 | |
Comment |
Number of Effective Vaccine Management (EVM) assessments completed with composite scores of 80% or higher | Value | 0.00 | 0.00 | 5.00 |
Date | June 30, 2021 | June 30, 2021 | June 30, 2024 | |
Comment |
Number of health departments with health facilities that have adopted COVID-19 related AEFI mechanisms | Value | 14.00 | 14.00 | 47.00 |
Date | June 30, 2021 | June 30, 2021 | June 30, 2024 | |
Comment |
Number of vaccination centers that have implemented standard operating procedures (SOPs) or guidelines updated for collection and disposal of COVID-19 vaccine related medical waste | Value | 24.00 | 24.00 | 57.00 |
Date | June 30, 2021 | June 30, 2021 | June 30, 2024 | |
Comment |